Potential effects and adverse reactions vary between individuals.
Dragon Pharma Gonadorelin 10 mg is a synthetic form of gonadotropin-releasing hormone (GnRH) designed for research applications. This peptide analog acts on the pituitary gland to stimulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), making it a valuable compound for studies related to reproductive physiology and hormonal regulation.
Each vial contains 10 mg of lyophilized Gonadorelin in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Gonadorelin is widely used in research settings to evaluate hypothalamic-pituitary-gonadal (HPG) axis function and to assess pituitary responsiveness in various experimental models. For related research compounds, explore our peptides category and specifically Kisspeptin 10 mg for complementary HPG axis modulation studies.
Gonadorelin serves as a critical tool for studying the neuroendocrine control of reproduction. Its ability to trigger the release of LH and FSH makes it useful for evaluating pituitary function and understanding the dynamics of the HPG axis. Researchers often use Gonadorelin in conjunction with other peptides to investigate hormonal feedback mechanisms and their role in reproductive health. For broader endocrine research, Sermorelin offers another pathway for evaluating growth hormone secretion dynamics.
Compared to other GnRH analogs, Gonadorelin retains the native amino acid sequence of endogenous GnRH, making it a standard reference compound for comparative studies. Its short half-life and rapid action require precise dosing and timing in experimental protocols. For a deeper understanding of GnRH physiology, researchers frequently consult the PubMed database for peer-reviewed literature.
Gonadorelin 10 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For investigators studying post-cycle recovery mechanisms, Enclomiphene represents another avenue for modulating the HPG axis in research models.
For research and laboratory use only. Dragon Pharma Gonadorelin 10 mg is a synthetic GnRH peptide. Proper reconstitution, handling, and experimental design are essential for obtaining reliable data.
Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 10 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.
In research settings, Gonadorelin is commonly administered via subcutaneous or intramuscular injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.
Research note: Gonadorelin is a short-acting peptide with a half-life of approximately 2–4 minutes. Experimental protocols should account for its rapid clearance when designing time-course studies and sampling schedules.
Third-party analytical testing (COA) for Dragon Pharma Gonadorelin 10 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.
This product is supplied through the official Dragon Pharma distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.
After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices during research use.
Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.
Gonadorelin is used in research to stimulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. It is commonly employed in studies of reproductive endocrinology and HPG axis function.
Reconstitute the lyophilized powder with sterile bacteriostatic water for injection. Add the appropriate volume, swirl gently until fully dissolved, and avoid vigorous shaking to preserve peptide integrity.
Reconstituted Gonadorelin should be stored at 2–8°C and used within 14 days. Discard any unused solution after this period to ensure stability and research accuracy.
Third-party laboratory testing for Gonadorelin 10 mg is currently pending. Batch-specific COA data will be published once analytical testing is completed and verified.
Researchers may combine Gonadorelin with other peptides to study hormonal interactions and feedback mechanisms. Stacking is determined by experimental design and research objectives.
Please log in to write GONADORELIN 10 MG review.
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 ML AMP x 5000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: MODERATE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: PRE-MIXED HUMAN CHORIONIC GONADOTROPIN
FORM: 1 VIAL x 10000 IU (READY-TO-INJECT)
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW to MODERATE
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY INCREASES ESTROGEN
MANUFACTURER: BHARAT SERUMS AND VACCINES
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: PRE-MIXED HUMAN CHORIONIC GONADOTROPIN
FORM: 1 VIAL x 5000 IU (READY-TO-INJECT)
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW to MODERATE
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY INCREASES ESTROGEN
MANUFACTURER: BHARAT SERUMS AND VACCINES
CLASSIFICATION: NATURAL HORMONE
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 AMP [2 ML PER AMP] x 10000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3 TIMES/WEEK (ON-CYCLE OR PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NO
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMACEUTICALS